Farallon Capital Management LLC and Maverick Capital Ltd: where the books meet
At Q2 2026, 11% of the two 13F books was the same, across 9 stocks both listed, against 12% at Q2 2013. Overlap is the smaller of each shared stock’s two weights, added up: the part of one book that could be swapped for the other’s without a trade.
- Q2 2013: 12%, 6 in both
- Q3 2013: 16%, 8 in both
- Q4 2013: 15%, 7 in both
- Q1 2014: 6.7%, 4 in both
- Q2 2014: 3.7%, 3 in both
- Q3 2014: 9.7%, 7 in both
- Q4 2014: 6.9%, 5 in both
- Q1 2015: 7.4%, 11 in both
- Q2 2015: 12%, 16 in both
- Q3 2015: 11%, 9 in both
- Q4 2015: 11%, 11 in both
- Q1 2016: 9.2%, 13 in both
- Q2 2016: 8.5%, 8 in both
- Q3 2016: 6.9%, 9 in both
- Q4 2016: 8.4%, 9 in both
- Q1 2017: 9.8%, 8 in both
- Q2 2017: 12%, 17 in both
- Q3 2017: 14%, 16 in both
- Q4 2017: 10%, 10 in both
- Q1 2018: 9.8%, 10 in both
- Q2 2018: 9.3%, 13 in both
- Q3 2018: 4.5%, 13 in both
- Q4 2018: 9.3%, 14 in both
- Q1 2019: 9.1%, 13 in both
- Q2 2019: 5.2%, 14 in both
- Q3 2019: 9.3%, 19 in both
- Q4 2019: 9.3%, 17 in both
- Q1 2020: 12%, 24 in both
- Q2 2020: 11%, 20 in both
- Q3 2020: 14%, 25 in both
- Q4 2020: 11%, 30 in both
- Q1 2021: 12%, 37 in both
- Q2 2021: 12%, 35 in both
- Q3 2021: 11%, 34 in both
- Q4 2021: 10%, 17 in both
- Q1 2022: 9.5%, 16 in both
- Q2 2022: 8.6%, 16 in both
- Q3 2022: 10%, 25 in both
- Q4 2022: 8.8%, 20 in both
- Q1 2023: 10%, 21 in both
- Q2 2023: 7.1%, 21 in both
- Q3 2023: 7.4%, 25 in both
- Q4 2023: 6.7%, 21 in both
- Q1 2024: 7.8%, 24 in both
- Q2 2024: 9.8%, 15 in both
- Q3 2024: 8.1%, 14 in both
- Q4 2024: 8.2%, 12 in both
- Q1 2025: 11%, 15 in both
- Q2 2025: 15%, 18 in both
- Q3 2025: 14%, 14 in both
- Q4 2025: 20%, 16 in both
- Q1 2026: 18%, 22 in both
- Q2 2026: 11%, 9 in both
Only quarters both managers filed. Where either filing has more positions than are read each quarter, a stock both hold below that range is not counted, so the figure is a floor.
What the overlap is made of, Q2 2026
Stocks both listed, by the smaller of the two weights. A weight is the stock’s share of that manager’s reported book, which says how large the position is, not how strongly it is held.
| Stock | Farallon Capital Management LLC | Maverick Capital Ltd |
|---|---|---|
| Amazon Com Inc(AMZN) | 2.9%Trimmed | 4.3%Trimmed |
| Natera Inc(NTRA) | 2.8%Trimmed | 3.3%Added |
| Boston Scientific Corp(BSX) | 2.1%Added | 2.2%Added |
| Microsoft Corp(MSFT) | 1.9%Trimmed | 2.7%Added |
| Roivant Sciences LTD(ROIV) | 2.3%Added | 0.9%Added |
| Novo-nordisk A S(NVO) | 0.6%Added | 0.7%Trimmed |
| Abivax SA(ABVX) | under 0.1%Added | under 0.1%New |
| Novartis A G(NVS) | 0.3%New | under 0.1%Added |
| Broadcom Inc(AVGO) | 2.0%Trimmed | under 0.1%New |
Moved different ways in Q2 2026
Stocks one manager started or added to while the other trimmed or sold out, between the same two quarter ends. A 13F shows the quarter ends, never when in between anything was bought or sold, or why.
- Natera Inc(NTRA)Farallon Capital Management LLC trimmed; Maverick Capital Ltd added
- Alphabet Inc(GOOG)Farallon Capital Management LLC sold out; Maverick Capital Ltd added
- Broadcom Inc(AVGO)Farallon Capital Management LLC trimmed; Maverick Capital Ltd started
- Microsoft Corp(MSFT)Farallon Capital Management LLC trimmed; Maverick Capital Ltd added
- Novo-nordisk A S(NVO)Farallon Capital Management LLC added; Maverick Capital Ltd trimmed
- Acadia Healthcare Company In(ACHC)Farallon Capital Management LLC added; Maverick Capital Ltd sold out
- Vaxcyte Inc(PCVX)Farallon Capital Management LLC sold out; Maverick Capital Ltd added
- Formfactor Inc(FORM)Farallon Capital Management LLC sold out; Maverick Capital Ltd started
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More